Summary
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
Source: The New York Times
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
